Ethyl 5-Acetyloxy-1,2-Dimethylindole-3-Carboxylate CAS 40945-79-7 Purity >99.0% Arbidol Hydrochloride Intermediate Factory

Short Description:

Name: Ethyl 5-Acetyloxy-1,2-Dimethylindole-3-Carboxylate

CAS: 40945-79-7

Purity (LCMS): >99.0%

Appearance: Off-White to Gray Powder

Intermediate of Arbidol Hydrochloride (CAS: 131707-23-8)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Ethyl 5-Acetyloxy-1,2-Dimethylindole-3-Carboxylate (CAS: 40945-79-7) with high quality, commercial production. Welcomed to order.

Chemical Properties:

Chemical Name	Ethyl 5-Acetyloxy-1,2-Dimethylindole-3-Carboxylate
Synonyms	Ethyl 5-Acetoxy-1,2-Dimethyl-1H-Indole-3-Carboxylate
CAS Number	40945-79-7
CAT Number	RF-PI1563
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C15H17NO4
Molecular Weight	275.30
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Off-White to Gray Powder
1 H NMR Spectrum	Consistent With Structure
LCMS	Consistent With Structure
Purity (LCMS)	>99.0%
Loss on Drying	<1.00%
Test Standard	Enterprise Standard
Usage	Intermediate of Arbidol Hydrochloride (CAS: 131707-23-8)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

FAQ:

Application:

Ethyl 5-Acetyloxy-1,2-Dimethylindole-3-Carboxylate (CAS: 40945-79-7) is an intermediate of Arbidol Hydrochloride (CAS: 131707-23-8). Arbidol Hydrochloride is a kind of double-effect anti-influenza various drug developed by the research center of the chemical drug (former Soviet) and can simultaneously fight against the influenza caused by both influenza virus A and B while may also have antiviral activity against other kinds of certain respiratory viral infections. Arbidol Hydrochloride has been first approved for entering into market in 1993 in Russia for the control of influenza s well as other acute respiratory viral infections.